Prexton Therapeutics

Contact
prextontherapeutics.com
+41 22 706 90 10

Prexton Therapeutics

14 chemin des Aulx
1228 Plan les Ouat Genf
Switzerland
+41 22 706 90 10
prextontherapeutics.com
Contact
Profile News
Contact

About Prexton Therapeutics

Recently founded in Geneva, Switzerland, Prexton Therapeutics is developing novel mGluR4 PAM series.

Read more about Prexton Therapeutics
Facts about Prexton Therapeutics
  • Industry : Pharma

News about Prexton Therapeutics

Prexton Therapeutics

26-Feb-2015 | business & finance

Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round

Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures ...

Read news
Prexton Therapeutics

29-Jan-2013 | business & finance

Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop mGluR4 PAMs for Parkinson’s disease

Domain Therapeutics S.A. announced that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate ...

Read news
Show more news about Prexton Therapeutics

Here you will find Prexton Therapeutics